Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
about
Religiosity, spirituality, and HIV risk behaviors among African American women from four rural counties in the southeastern U.S.Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infectionsProgram collaboration and service integration activities among HIV programs in 59 U.S. health departmentsConceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.Prevention, early intervention, and harm reduction of substance use in adolescents.Cohort profile: seek, test, treat and retain United States criminal justice cohortEstimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners.HIV testing among adults with mental illness in the United States.Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus.Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centersA Brief Screening Tool to Assess the Risk of Contracting HIV Infection Among Active Injection Drug Users.Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs.Women, drugs and HIV.Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.The Impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a Systematic Review : Alcohol and the HIV Continuum of Care.Racialized risk environments in a large sample of people who inject drugs in the United States.Cost-Effectiveness of Frequent HIV Testing of High-Risk Populations in the United States.HIV Testing, HIV Positivity, and Linkage and Referral Services in Correctional Facilities in the United States, 2009-2013Managing tuberculosis in people who use and inject illicit drugs.Exploring Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection Recruited with Venue-based SamplingFinding what works: identification of implementation strategies for the integration of methadone maintenance therapy and HIV services in VietnamFactors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection in New York CityHIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013.Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.Addressing the Medical and Support Service Needs of People Living with HIV (PLWH) through Program Collaboration and Service Integration (PCSI).Thirty years of the human immunodeficiency virus epidemic and beyond.Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.Monetary conversion factors for economic evaluations of substance use disorders.Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic.Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037.Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.People Who Inject Drugs and Have Mood Disorders-A Brief Assessment of Health Risk Behaviors.Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach.Lifetime risk of a diagnosis of HIV infection in the United States.A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
P2860
Q27336081-8C76AA24-020D-4706-99A5-B0FF6317559BQ28538968-52F5C8C0-6D84-4CE9-A471-10B046AEAC9BQ28661119-D4A829A6-AA10-4B7D-AC04-3F8C00432271Q30238798-EA54D1D6-2F26-4F79-95AB-4653E57CD958Q33641576-E7BED0F9-831E-444E-AA86-60A0278D2D51Q33691666-D82973FA-DDF2-49C1-83BE-86F7311BFD40Q33724701-611FF0A0-2DC1-4B34-AA0F-B6BC06BE1285Q34169506-E1EFBD22-97F7-4EC2-8AD8-75AA763728C4Q34606525-90F7B538-BF8A-4DE2-A092-75B38B5EB933Q35098577-FE88BD02-19CC-4CA5-85F3-E77A23D775F7Q35112836-5E3D0735-9F95-4055-A243-81A3EA325A6AQ35626674-87F6A2AA-720A-430F-BBCA-84255AAEF118Q35749923-D7B1E91F-220E-4F1B-9935-147742D8781FQ35838614-0684A4B3-EA1D-461A-9A24-C76EF1AD63E2Q36090286-E95E6B20-6459-492B-90EB-B437151203B7Q36257356-79935B5A-2092-47D3-A947-311CA6D5F699Q36275929-724C668C-5DD6-490B-BA78-2A5AB099A26AQ36471364-7DFAB2E9-AC3D-4156-A49B-45050A3A6C60Q36628388-2295F6B0-20A9-4A3B-BC58-6F7AB7900F62Q36636547-00720B6F-607E-40D3-9F69-90AA1286A9A7Q36707026-81CFE3D1-91D6-4018-B88D-3CC99C081BCDQ36813072-078BF5B5-1B48-459A-82D7-40B9422DF3EFQ36815377-0F899F53-6961-4885-86BE-803ABCF85DFBQ36840494-C37395B4-53EF-4BDD-BE01-3EB96564C78FQ37014523-FE94A796-F02E-435E-8C76-292E2EE0001FQ37040594-D80273B4-06F3-4F66-B82D-DB970CB38526Q37140446-E3E43B7F-21FE-48F2-8AE2-09627B171C9CQ37466864-7579FEBF-8F17-44C9-B251-7ED907C529A4Q37650296-682E65CE-B014-4F7C-BE71-398F5330C5E8Q37667360-E89C55FF-CB88-4BF8-B718-1D42126BBB4FQ37696114-2BEA3CD4-BB6C-41B8-BA10-E560D5683E13Q38372109-E974FF0B-12EB-456A-B54D-E64878225C3AQ38605382-C40C581F-B353-42E8-B246-E9F7AD99C7B8Q38615955-04689CAA-9EEE-49AD-A878-851B0F48FE9BQ38620433-A47779AC-6671-4FBE-A9E8-247DB74AA75FQ38730582-B6ACFE36-1572-44FE-8989-9AF9E3F9F1E5Q38748758-763BB59A-049D-4ABF-AA76-0F91597B46DDQ38785346-CCA0CB89-F2E4-4FAA-8813-06A920F1E563Q38888885-F0346B30-BADF-4E38-AE8C-878FF9675FDDQ40075326-45AD5685-20DC-4F3F-996D-D2621F8A69B3
P2860
Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Integrated prevention services ...... of Health and Human Services.
@en
Integrated prevention services ...... of Health and Human Services.
@nl
type
label
Integrated prevention services ...... of Health and Human Services.
@en
Integrated prevention services ...... of Health and Human Services.
@nl
prefLabel
Integrated prevention services ...... of Health and Human Services.
@en
Integrated prevention services ...... of Health and Human Services.
@nl
P921
P1476
Integrated prevention services ...... t of Health and Human Services
@en
P577
2012-11-01T00:00:00Z